Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check4 days agoChange DetectedRelated topics including Prostate cancer and MedlinePlus Genetics were removed from the page.SummaryDifference0.6%

- Check11 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics. These changes enhance topic tagging and navigation for this prostate cancer study.SummaryDifference0.2%

- Check33 days agoChange DetectedVersion bump to v3.2.0 with a government funding lapse notice; previous v3.1.0 reference removed.SummaryDifference4%

- Check40 days agoChange DetectedAdds updated contact details and a new revision identifier (v3.1.0); removes the Prostate cancer topic from MedlinePlus Genetics and references an older revision (v3.0.2).SummaryDifference0.4%

- Check47 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer. No deletions observed.SummaryDifference0.3%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a patch-level update. The Back to Top link was removed, reducing navigation convenience but not affecting core content.SummaryDifference0.3%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.